Denice Torres

Director, bluebird bio.

Companies

Seaport Therapeutics, Inc.Board member Apr 30, 2026 to now¹
Celldex TherapeuticsBoard member Jun 6, 2025 to now²
2seventy bio, Inc.Board member Oct 18, 2021 to now³
GLAUKOS CorpBoard member Mar 3, 2021 to now⁴
Karuna TherapeuticsBoard member Dec 22, 2020 to Mar 18, 2024⁵
Surface Oncology, Inc.Board member Jul 8, 2021 to Jun 10, 2022⁶
bluebird bioBoard member Aug 11, 2020 to Nov 17, 2021⁷

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

GLAUKOS Corp GKOS24,212 shares⁸$4.0M at $165.60May 28, 2026
Seaport Therapeutics, Inc. SPTX13,406 shares⁹$235.5K at $17.57May 4, 2026
bluebird bio BLUE2,726 shares¹⁰Nov 11, 2021
Karuna Therapeutics KRTX0 shares¹¹Mar 18, 2024
2seventy bio, Inc.0 shares¹²May 13, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

May 28, 2026Granted 1,878 shares of GLAUKOS Corp⁸
May 4, 2026Converted 13,406 shares of Seaport Therapeutics, Inc.⁹
Jan 2, 2026Granted 623 shares of GLAUKOS Corp¹³
May 29, 2025Granted 2,108 shares of GLAUKOS Corp¹⁴
May 13, 2025U 19,510 shares of 2seventy bio, Inc.¹²
May 13, 2025Returned to company 12,050 shares of 2seventy bio, Inc.¹²
Jan 2, 2025Granted 461 shares of GLAUKOS Corp¹⁴
Jun 10, 2024Granted 12,050 shares of 2seventy bio, Inc.¹⁵
May 30, 2024Granted 1,716 shares of GLAUKOS Corp¹⁶
Mar 18, 2024Returned to company 990 shares at $330.00 of Karuna Therapeutics¹¹
Jan 2, 2024Granted 895 shares of GLAUKOS Corp¹⁷
Jun 20, 2023Granted 990 shares of Karuna Therapeutics¹⁸
Jun 13, 2023Granted 8,400 shares of 2seventy bio, Inc.¹⁹
Jun 1, 2023Granted 3,230 shares of GLAUKOS Corp²⁰
Jan 3, 2023Granted 1,572 shares of GLAUKOS Corp²¹
Jun 8, 2022Granted 8,200 shares of 2seventy bio, Inc.²²
Jun 2, 2022Granted 4,364 shares of GLAUKOS Corp²³
Jan 3, 2022Granted 1,455 shares of GLAUKOS Corp²⁴
Nov 11, 2021Other of bluebird bio¹⁰
Nov 11, 2021Granted 2,002 shares of 2seventy bio, Inc.²⁵
Nov 11, 2021Other 1,476 shares of bluebird bio¹⁰
Nov 11, 2021Granted 492 shares of 2seventy bio, Inc.²⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSeaport Therapeutics, Inc., Board member
2
SEC EDGARCelldex Therapeutics, Board member
3
SEC EDGAR2seventy bio, Inc., Board member
4
SEC EDGARGLAUKOS Corp, Board member
5
SEC EDGARKaruna Therapeutics, Board member
6
SEC EDGARSurface Oncology, Inc., Board member
7
SEC EDGARbluebird bio, Board member
8
SEC EDGARGLAUKOS Corp shares after the filing of May 28, 2026
9
SEC EDGARSeaport Therapeutics, Inc. shares after the filing of May 4, 2026
10
SEC EDGARbluebird bio shares after the filing of Nov 11, 2021
11
SEC EDGARKaruna Therapeutics shares after the filing of Mar 18, 2024
12
SEC EDGAR2seventy bio, Inc. shares after the filing of May 13, 2025
13
SEC EDGARForm 4 filed Jan 7, 2026
14
SEC EDGARForm 4 filed Jun 2, 2025
15
SEC EDGARForm 4 filed Jun 12, 2024
16
SEC EDGARForm 4 filed Jun 3, 2024
17
SEC EDGARForm 4 filed Jan 4, 2024
18
SEC EDGARForm 4 filed Jun 22, 2023
19
SEC EDGARForm 4 filed Jun 15, 2023
20
SEC EDGARForm 4 filed Jun 5, 2023
21
SEC EDGARForm 4 filed Jan 4, 2023
22
SEC EDGARForm 4 filed Jun 9, 2022
23
SEC EDGARForm 4 filed Jun 6, 2022
24
SEC EDGARForm 4 filed Jan 5, 2022
25
SEC EDGARForm 4 filed Nov 16, 2021